Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Keyue Ding
Affiliation
Queen's University
ORCID
Career Start Year
2002
Papers
163
H Index
49
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
36272526
Benefit of adjuvant chemotherapy for resected pathologic N1 non-small cell lung cancer is unrecognized: A subgroup analysis of the JBR10 trial.
Semin Thorac Cardiovasc Surg
2024
36493331
Mepitel Film for the Prevention of Acute Radiation Dermatitis in Breast Cancer: A Randomized Multicenter Open-Label Phase III Trial.
J Clin Oncol
2023
37847995
Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group.
J Clin Oncol
2023
37584828
Mepitel film for the prevention and treatment of acute radiation dermatitis in breast cancer: a systematic review and meta-analysis of randomized controlled trials.
Support Care Cancer
2023
37814061
ctDNA response after pembrolizumab in non-small cell lung cancer: phase 2 adaptive trial results.
Nat Med
2023
37273168
Molecular evolution in different subtypes of multifocal hepatocellular carcinoma.
Hepatol Int
2023
36731620
A comparison of algorithms for identifying copy number variants in family-based whole-exome sequencing data and its implications in inheritance pattern analysis.
Gene
2023
34800700
CCTG BR34: A Randomized Phase 2 Trial of Durvalumab and Tremelimumab With or Without Platinum-Based Chemotherapy in Patients With Metastatic NSCLC.
J Thorac Oncol
2022
35404908
Quantitative Evidence for Early Metastasis in a Pancreatic Acinar Cell Carcinoma Patient.
Pancreas
2022
36395415
Neoantigen-Based Immunotherapy for a Long-Term Survivor With Pancreatic Neuroendocrine Tumor.
Pancreas
2022
35098127
Corrigendum to: Impact of lymphopenia on survival for elderly patients with glioblastoma: A secondary analysis of the CCTG CE.6 (EORTC 26062-22061, TROG 08.02) randomized clinical trial.
Neurooncol Adv
2022
35274718
Complementary Medicine Use Amongst Patients with Metastatic Cancer Enrolled in Phase III Clinical Trials.
Oncologist
2022
35266334
Deep phenotyping and whole-exome sequencing improved the diagnostic yield for nuclear pedigrees with neurodevelopmental disorders.
Mol Genet Genomic Med
2022
35134877
PSL-LCCL: a resource for subcellular protein localization in liver cancer cell line SK_HEP1.
Database (Oxford)
2022
33390282
The Association Between Statin Use and Outcomes in Patients Initiating Androgen Deprivation Therapy.
Eur Urol
2021
33570546
Evaluation of Efficacy and Safety of Nab-Paclitaxel vs Paclitaxel in Platinum-Refractory Metastatic Urothelial Cancer-Reply.
JAMA Oncol
2021
34765975
Impact of lymphopenia on survival for elderly patients with glioblastoma: A secondary analysis of the CCTG CE.6 (EORTC 26062-22061, TROG03.01) randomized clinical trial.
Neurooncol Adv
2021
34383590
Reply by Authors.
J Urol
2021
34509461
Early dynamic changes of quasispecies in the reverse transcriptase region of hepatitis B virus in telbivudine treatment.
Antiviral Res
2021
34478669
Stereotactic body radiotherapy for painful spinal metastases - Authors' reply.
Lancet Oncol
2021
34184929
Interpreting Testosterone and Concomitant Prostate Specific Antigen Values during Androgen Deprivation Therapy for Recurrent Prostate Cancer.
J Urol
2021
34350138
DNA and RNA Sequencing Recapitulated Aberrant Tumor Metabolism in Liver Cancer Cell Lines.
J Hepatocell Carcinoma
2021
34126044
Stereotactic body radiotherapy versus conventional external beam radiotherapy in patients with painful spinal metastases: an open-label, multicentre, randomised, controlled, phase 2/3 trial.
Lancet Oncol
2021
33982971
Metastatic Timing and Genetic Heterogeneity in the Evolution of a Pancreatic Neuroendocrine Tumor.
Am J Gastroenterol
2021
32220948
Immunohistochemical validation study of 15-gene biomarker panel predictive of benefit from adjuvant chemotherapy in resected non-small-cell lung cancer: analysis of JBR.10.
ESMO Open
2020
33997170
Depletion of <i>VPS35</i> attenuates metastasis of hepatocellular carcinoma by restraining the Wnt/PCP signaling pathway.
Genes Dis
2020
31845837
Extragonadal Steroids Contribute Significantly to Androgen Receptor Activity and Development of Castration Resistance in Recurrent Prostate Cancer after Primary Therapy.
J Urol
2020
32071398
DNA and RNA sequencing identified a novel oncogene VPS35 in liver hepatocellular carcinoma.
Oncogene
2020
33427654
CCTG SC.24/TROG 17.06: A Randomized Phase II/III Study Comparing 24Gy in 2 Stereotactic Body Radiotherapy (SBRT) Fractions Versus 20Gy in 5 Conventional Palliative Radiotherapy (CRT) Fractions for Patients with Painful Spinal Metastases.
Int J Radiat Oncol Biol Phys
2020
33329702
Integrative Analysis Extracts a Core ceRNA Network of the Fetal Hippocampus With Down Syndrome.
Front Genet
2020
32632894
Temozolomide and seizure outcomes in a randomized clinical trial of elderly glioblastoma patients.
J Neurooncol
2020
32940628
Efficacy and Safety of nab-Paclitaxel vs Paclitaxel on Survival in Patients With Platinum-Refractory Metastatic Urothelial Cancer: The Canadian Cancer Trials Group BL.12 Randomized Clinical Trial.
JAMA Oncol
2020
32708705
Metabolites as Prognostic Markers for Metastatic Non-Small Cell Lung Cancer (NSCLC) Patients Treated with First-Line Platinum-Doublet Chemotherapy.
Cancers (Basel)
2020
32391232
Cryosurgery Versus Primary Androgen Deprivation Therapy for Locally Recurrent Prostate Cancer After Primary Radiotherapy: A Propensity-Matched Survival Analysis.
Cureus
2020
32348812
An ontology-based classification of Ebstein's anomaly and its implications in clinical adverse outcomes.
Int J Cardiol
2020
30784428
Using natural language processing to extract clinically useful information from Chinese electronic medical records.
Int J Med Inform
2019
31695090
Transcriptomic Analysis of mRNA-lncRNA-miRNA Interactions in Hepatocellular Carcinoma.
Sci Rep
2019
31598937
[Analysis of MYO7A gene mutation in a family with non-syndromic autosomal recessive deafness].
Zhonghua Yi Xue Yi Chuan Xue Za Zhi
2019
29188483
Minimal clinically important differences in the EORTC QLQ-C30 and brief pain inventory in patients undergoing re-irradiation for painful bone metastases.
Qual Life Res
2018
30106638
Tumor Mutation Burden as a Biomarker in Resected Non-Small-Cell Lung Cancer.
J Clin Oncol
2018
30021911
Serum Sex Steroids as Prognostic Biomarkers in Patients Receiving Androgen Deprivation Therapy for Recurrent Prostate Cancer: A <i>Post Hoc</i> Analysis of the PR.7 Trial.
Clin Cancer Res
2018
29903505
Randomised Phase II Feasibility Trial of Image-guided External Beam Radiotherapy With or Without High Dose Rate Brachytherapy Boost in Men with Intermediate-risk Prostate Cancer (CCTG PR15/ NCT01982786).
Clin Oncol (R Coll Radiol)
2018
29102263
Gender and age make no difference in the re-irradiation of painful bone metastases: A secondary analysis of the NCIC CTG SC.20 randomized trial.
Radiother Oncol
2018
28950727
Patient Reported Outcomes After Radiation Therapy for Bone Metastases as a Function of Age: A Secondary Analysis of the NCIC CTG SC-Twenty-Three Randomized Trial.
Am J Hosp Palliat Care
2018
27502323
A Cost-Effectiveness Analysis of Using the JBR.10-Based 15-Gene Expression Signature to Guide Adjuvant Chemotherapy in Early Stage Non-Small-Cell Lung Cancer.
Clin Lung Cancer
2017
28196208
Effect of Radiotherapy on Painful Bone Metastases: A Secondary Analysis of the NCIC Clinical Trials Group Symptom Control Trial SC.23.
JAMA Oncol
2017
28332385
Genetic Risk, Lifestyle, and Coronary Artery Disease.
N Engl J Med
2017
28379421
Impact of baseline BMI and weight change in CCTG adjuvant breast cancer trials.
Ann Oncol
2017
28296618
Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma.
N Engl J Med
2017
29156912
Genetic biomarkers associated with pain flare and dexamethasone response following palliative radiotherapy in patients with painful bone metastases.
Ann Palliat Med
2017
1 - 50 of 163
Column Actions
Search
Recommended Authors
David C Qian
Winship Cancer Institute of Emory University
Career Start Year
2015
Number of shared co-authors
4
Osvaldo Espin-Garcia
Princess Margaret Cancer Centre, University Health Network
Career Start Year
2013
Number of shared co-authors
11
Xin Qiu
SLR Consulting (Canada) Ltd
Career Start Year
2012
Number of shared co-authors
9
Guanglong Jiang
Indiana University School of Medicine
Career Start Year
2011
Number of shared co-authors
0
Daniel J Serie
Mayo Clinic
Career Start Year
2010
Number of shared co-authors
1
Chen Hu
Johns Hopkins University School of Medicine
Career Start Year
2009
Number of shared co-authors
1
Qiyuan Li
National Institute of Data Science in Health and Medicine, Xiamen University
Career Start Year
2008
Number of shared co-authors
1
Eric C Polley
Mayo Clinic
Career Start Year
2007
Number of shared co-authors
0
Eunjee Lee
Chungnam National University
Career Start Year
2007
Number of shared co-authors
1
Yang Xie
Quantitative Biomedical Research Center
Career Start Year
2007
Number of shared co-authors
1
Kouros Owzar
Duke University
Career Start Year
2005
Number of shared co-authors
3
Abul Kalam Azad
University of Dhaka
Career Start Year
2004
Number of shared co-authors
11
Wenhua Liang
The First People's Hospital of Zhaoqing
Career Start Year
2003
Number of shared co-authors
1
Brooke L Fridley
H. Lee Moffitt Cancer Center and Research Institute
Career Start Year
2003
Number of shared co-authors
9
Michael Slifker
Fox Chase Cancer Center
Career Start Year
2002
Number of shared co-authors
0
Syed Haider
Institute of Cancer Research
Career Start Year
2002
Number of shared co-authors
10
Gregory D Jenkins
Mayo Clinic
Career Start Year
2001
Number of shared co-authors
6
Cristina Rodr??guez-Antona
Spanish National Cancer Research Center (CNIO)
Career Start Year
2000
Number of shared co-authors
0
Pingfu Fu
Case Western Reserve University
Career Start Year
2000
Number of shared co-authors
9
Yan W Asmann
Mayo Clinic
Career Start Year
2000
Number of shared co-authors
10
Hugues Sicotte
Mayo Clinic
Career Start Year
1999
Number of shared co-authors
11
Liewei Wang
Mayo Clinic
Career Start Year
1999
Number of shared co-authors
11
Elizabeth Garrett-Mayer
Center for Research and Analytics, American Society of Clinical Oncology
Career Start Year
1997
Number of shared co-authors
3
David Elashoff
David Geffen School of Medicine at University of California los angeles
Career Start Year
1997
Number of shared co-authors
2
Woong-Yang Park
Samsung Genome Institute, Samsung Medical Center
Career Start Year
1995
Number of shared co-authors
2
Sudhir Varma
Center for Cancer Research, National Cancer Institute
Career Start Year
1994
Number of shared co-authors
0
Wei Xu
Princess Margaret Cancer Centre
Career Start Year
1991
Number of shared co-authors
25
Jong-Il Kim
Genomic Medicine Institute, Medical Research Center, Seoul National University
Career Start Year
1989
Number of shared co-authors
0
Luigi Marchionni
Weill-Cornell School of Medicine
Career Start Year
1989
Number of shared co-authors
2
Stephen J Chanock
National Cancer Institute, National Institutes of Health
Career Start Year
1983
Number of shared co-authors
25
row(s) 1 - 30 of 30
Collaborators
Frances A Shepherd
University Health Network, Princess Margaret Cancer Centre
Co-authored papers
45
Iftikhar J Kullo
Mayo Clinic
Co-authored papers
21
Michael Brundage
Cancer Centre of Southeastern Ontario
Co-authored papers
19
Edward Chow
University of Toronto
Co-authored papers
18
Ming-Sound Tsao
University Health Network, University of Toronto
Co-authored papers
18
Yan Shen
Center for Trauma and Acute Care Surgery Research, Clinical Services Group
Co-authored papers
11
Lois Shepherd
Queens University
Co-authored papers
8
Ni Liu
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Co-authored papers
6
Mariza de Andrade
Mayo Clinic
Co-authored papers
5
Chang-Qi Zhu
Princess Margaret Cancer Centre, University Health Network
Co-authored papers
5
Warren P Mason
Princess Margaret Cancer Centre
Co-authored papers
4
Ryo Nishikawa
Saitama Medical University International Medical Center
Co-authored papers
4
Marylyn D Ritchie
Center for Systems Genomics, Pennsylvania State University, University Park
Co-authored papers
4
Peter Hoskin
Mount Vernon Cancer Centre
Co-authored papers
4
Christopher G Chute
Brown University, Brown University Warren Alpert Medical School, Dartmouth-Hitchcock Medical Center, Harvard School of Public Health, Johns Hopkins Medicine, Mayo Clinic Minnesota
Co-authored papers
4
Hayan Jouni
Mayo Clinic
Co-authored papers
4
William F Hartsell
Proton Therapy Center- Northwestern University
Co-authored papers
4
Eric M Horwitz
Fox Chase Cancer Center
Co-authored papers
4
Khader Shameer
School of Public Health, Imperial College London
Co-authored papers
4
William F Demas
Salem Regional Medical Center
Co-authored papers
4
Paul Wheatley-Price
The Ottawa Hospital Research Institute
Co-authored papers
3
Abel N Kho
Northwestern University Feinberg School of Medicine
Co-authored papers
3
Eric Boerwinkle
Baylor College of Medicine
Co-authored papers
3
Stephen T Turner
Mayo Clinic
Co-authored papers
3
Catherine A McCarty
University of Minnesota Medical School, 1035 University Drive duluth
Co-authored papers
3
Joshua C Denny
Vanderbilt University
Co-authored papers
3
Jeremy A Squire
University of Sao Paulo
Co-authored papers
3
Kim N Chi
University of British Columbia
Co-authored papers
3
Gail P Jarvik
University of Washington Medical Center
Co-authored papers
3
Daniel R Masys
University of Washington School of Medicine.
Co-authored papers
3
1 - 30